Jiangxi YBN Pharmaceutical Co.,Ltd

Jiangxi YBN Pharmaceutical Co., Ltd. established in May 1999 and located at Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province where is at the foot of the revolutionary cradle of Jinggangshan. The company is a national high-tech enterprise specializing in the research and development, production, and sales of drugs, health food, and bee products. The company currently has a research and development production base of 27,000m2, a production and operational building area of 31,000m2, and multiple production lines and inspection and testing equipment for drugs, health food, food, and honey products. The company currently has over 100 invention, utility model, and appearance patents, and has obtained drug production licenses and food production licenses. It has obtained drug production license, food production license, HACCP certification, BRC certification, FDA certification and so on. It has also been awarded multiple honorary titles such as "Advanced Enterprise in Science and Technology Innovation in Jinggangshan Economic and Technological Development Zone", "National Health Food Industry Quality Demonstration Unit", "National Integrity Management, Quality and Credit Keeping Enterprise", "Jiangxi Province Quality and Quality Standard Reliable Enterprise", "AAA Class Credit Enterprise", and so on. The products are exported to Southeast Asia and the European Union. Both calcium gluconate (oral use) and calcium gluconate (injection) are made from raw materials that meet or exceed the quality standards of the 2020 edition of the "Chinese Pharmacopoeia". This product adopts advanced enzymatic synthesis processes both domestically and internationally, and uses advanced production equipment. The quality of the raw materials for oral and injection use meets (or exceeds) the quality standards of the 2020 edition of the "Chinese Pharmacopoeia", All exported products comply with USP43, EP11, BP2022 and other pharmacopoeia standards. The registration standard for calcium gluconate (oral use) is implemented in accordance with the "Revised Draft of the National Drug Standard for Calcium Gluconate"; on the basis of the testing items in the 2020 edition of the "Chinese Pharmacopoeia", 9 test items have been added, and the testing standards for some test items have been improved accordingly. The registration standard for calcium gluconate (injection) is implemented in accordance with the "Revised Draft of the National Drug Standard for Calcium Gluconate"; on the basis of the testing items in the 2020 edition of the "Chinese Pharmacopoeia", 12 test items have been added, and the testing standards of some test items has been improved accordingly. The main raw materials glucose and zinc oxide are made from raw materials that meet or exceed the quality standards of the 2020 edition of the "Chinese Pharmacopoeia". This product adopts advanced enzymatic synthesis process at home and abroad and uses advanced production equipment. The quality of the product meets or exceeds the quality standards of the 2020 edition of "Chinese Pharmacopoeia"; All exported products comply with USP43, EP11, BP2022 and other pharmacopoeia standards. on the basis of the 2020 edition of "Chinese Pharmacopoeia", 7 test items have been added, and the testing standards of some test items have been improved accordingly.